The impact of SARS-COV-2 infection on menstruation.
Abnormal uterine bleeding
COVID-19
Menstrual cycle
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
16 Nov 2023
16 Nov 2023
Historique:
received:
27
04
2023
accepted:
09
10
2023
medline:
20
11
2023
pubmed:
17
11
2023
entrez:
17
11
2023
Statut:
epublish
Résumé
Recent study has demonstrated that the GnRH system in patients with post-COVID syndrome may be influenced by SARS-CoV-2. However, the impact of COVID-19 infection on women's menstruation is still unknown. We aimed to investigate the the relationship between coronavirus disease 2019 (COVID-19) and menstruation in premenopausal women. This was a retrospective cohort study. Pre-menopausal women were invited to participate in the online questionnaire on wechat. Participants were divided into four groups according to whether they were infected with severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) and whether they had menstrual changes during the pandemic. Sociodemographic characteristics, history of COVID-19, menstruation and menstrual changes of the participants were collected. Statistical analyses were performed using SPSS, version 25.0 (SPSS Inc., Chicago, IL, USA). A total of 1946 women were included in the study. 1800 participants had been or were currently infected with SARS-COV-2, and 146 people had not been infected. Among 1800 patients with COVID-19, 666 (37.0%) had changes in menstruation, and 1134 (63.0%) did not, which was significantly higher than the uninfected participants (c The association between the COVID-19 and increased prevalence of menstrual cycle irregularity. COVID-19 vaccination is a protective factor in the long term, and participants with chest pain and dyspnea are more likely to develop AUB.
Sections du résumé
BACKGROUND
BACKGROUND
Recent study has demonstrated that the GnRH system in patients with post-COVID syndrome may be influenced by SARS-CoV-2. However, the impact of COVID-19 infection on women's menstruation is still unknown.
OBJECTIVE
OBJECTIVE
We aimed to investigate the the relationship between coronavirus disease 2019 (COVID-19) and menstruation in premenopausal women.
METHODS
METHODS
This was a retrospective cohort study. Pre-menopausal women were invited to participate in the online questionnaire on wechat. Participants were divided into four groups according to whether they were infected with severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) and whether they had menstrual changes during the pandemic. Sociodemographic characteristics, history of COVID-19, menstruation and menstrual changes of the participants were collected. Statistical analyses were performed using SPSS, version 25.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
RESULTS
A total of 1946 women were included in the study. 1800 participants had been or were currently infected with SARS-COV-2, and 146 people had not been infected. Among 1800 patients with COVID-19, 666 (37.0%) had changes in menstruation, and 1134 (63.0%) did not, which was significantly higher than the uninfected participants (c
CONCLUSIONS
CONCLUSIONS
The association between the COVID-19 and increased prevalence of menstrual cycle irregularity. COVID-19 vaccination is a protective factor in the long term, and participants with chest pain and dyspnea are more likely to develop AUB.
Identifiants
pubmed: 37974147
doi: 10.1186/s12905-023-02697-2
pii: 10.1186/s12905-023-02697-2
pmc: PMC10655360
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
611Subventions
Organisme : National Natural Science Foundation of China
ID : 82001504
Organisme : National Natural Science Foundation of China
ID : 82171670
Informations de copyright
© 2023. The Author(s).
Références
Science. 2022 Nov 18;378(6621):704-706
pubmed: 36395209
Fertil Steril. 2022 Dec;118(6):1159-1169
pubmed: 36333264
Reprod Biomed Online. 2021 Oct;43(4):769
pubmed: 34489182
Int J Gynaecol Obstet. 2020 Jul;150(1):98-102
pubmed: 32392400
Health Sci Rep. 2022 Oct 08;5(6):e881
pubmed: 36248348
Int J Epidemiol. 2022 Jun 13;51(3):691-700
pubmed: 34865021
Bull Natl Res Cent. 2022;46(1):170
pubmed: 35729950
Mucosal Immunol. 2021 Sep;14(5):991-1005
pubmed: 33903735
Int J Gynaecol Obstet. 2018 Dec;143(3):393-408
pubmed: 30198563
Am J Obstet Gynecol. 2022 Nov;227(5):739.e1-739.e11
pubmed: 35841938
Front Med (Lausanne). 2021 Mar 19;8:635255
pubmed: 33816526
J Midlife Health. 2022 Jul-Sep;13(3):225-232
pubmed: 36950211
J Clin Med. 2022 Jun 30;11(13):
pubmed: 35807090
Reprod Biomed Online. 2021 Jan;42(1):260-267
pubmed: 33288478
PLoS One. 2022 Jun 29;17(6):e0270537
pubmed: 35767537
Front Reprod Health. 2022 Jul 22;4:927211
pubmed: 36303671
J Obstet Gynaecol Res. 2021 Sep;47(9):3241-3249
pubmed: 34137123
EBioMedicine. 2023 Oct;96:104784
pubmed: 37713808
Fertil Steril. 2023 Mar;119(3):392-400
pubmed: 36539055
Int J Clin Pract. 2022 Oct 27;2022:3199758
pubmed: 36349056
Womens Health Issues. 2004 Nov-Dec;14(6):235-41
pubmed: 15589774
Front Endocrinol (Lausanne). 2022 Apr 01;13:838886
pubmed: 35432198
Autoimmun Rev. 2012 May;11(6-7):A486-92
pubmed: 22155200
Am J Obstet Gynecol. 2022 Feb;226(2):270-273
pubmed: 34555320
Reprod Biomed Online. 2022 Jul;45(1):153-158
pubmed: 35523708
Front Immunol. 2019 Oct 17;10:2387
pubmed: 31681281
Front Endocrinol (Lausanne). 2021 Mar 22;12:642755
pubmed: 33841334
Nat Rev Microbiol. 2023 Mar;21(3):133-146
pubmed: 36639608